Monitoring circulating dipeptidyl peptidase 3 (DPP3) predicts improvement of organ failure and survival in sepsis: a prospective observational multinational study.
Alice BletBenjamin DeniauKarine SantosDirk P T van LierFeriel AzibaniXavier WitteboleBenjamin G ChoustermanEtienne GayatOliver HartmannJoachim StruckAndreas BergmannMassimo AntonelliAlbertus BeishuizenJean-Michel ConstantinCharles DamoiselNicolas DeyeSalvatore Di SommaThierry DugernierBruno FrançoisStephane GaudryVincent HuberlantJean-Baptiste LascarrouGernot MarxEmmanuelle MercierHaikel OueslatiPeter PickkersRomain SonnevilleMatthieu LegrandPierre-François LaterreAlexandre Mebazaanull nullPublished in: Critical care (London, England) (2021)
Admission levels and rapid changes in cDPP3 predict outcome during sepsis. Trial Registration ClinicalTrials.gov, NCT02393781. Registered on March 19, 2015.